Summary
This 8-K filing from Becton, Dickinson and Company (BDX) reports on stock option exercises and sales by Vincent A. Forlenza, President of BD Biosciences. On February 24, 2004, Mr. Forlenza exercised options for 97,612 shares granted in 1996, which were set to expire in January 2006. He subsequently sold these shares. Additionally, he purchased 7,613 shares through the exercise of other stock options. These transactions result in an increase in Mr. Forlenza's beneficial ownership of BDX shares, excluding unexercised options, to 47,632. The company emphasizes that his ownership remains well above the required level stipulated by BD's share ownership guidelines, which mandate ownership equivalent to at least three times his salary. The reported transactions are framed as part of Mr. Forlenza's personal financial strategy for asset diversification and liquidity.
Key Highlights
- 1Disclosure of stock option exercise and sale by Vincent A. Forlenza, President - BD Biosciences.
- 2Mr. Forlenza exercised options for 97,612 shares of BDX stock.
- 3The exercised options were originally granted in 1996 and were due to expire in January 2006.
- 4Following the exercise, Mr. Forlenza sold the acquired shares.
- 5Mr. Forlenza also purchased an additional 7,613 shares via option exercise.
- 6His beneficial ownership of BDX shares (excluding options) increased to 47,632.
- 7The company notes that his ownership exceeds BD's stock ownership guidelines (at least 3x salary).